StonvexLoading…
StonvexStonvexStonvexCore line items from MPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $252.06M | $972.02M | $701.68M | $464.16M |
Operating Income | $285.00K | $-237.32M | $-263.42M | $-196.84M |
Net Income | $32.83M | $-277.05M | $-294.36M | $-216.63M |
EPS (Diluted) | $0.05 | $-0.46 | $-0.49 | $-0.36 |
Total Assets | $14.76B | $15.00B | $14.92B | $15.15B |
Total Liabilities | $10.22B | $10.39B | $10.26B | $10.32B |
Cash & Equivalents | $425.00M | $540.86M | $396.58M | $509.83M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 597.72M | 597.01M | 601.14M | 600.81M |